Milestones
- Eterna development2018Complete.
- FDA approvalDec 2022Complete.
- Market launchQ1 2023Complete.
Smallest rechargeable SCS system for chronic pain. Uses low-dose BurstDR stimulation.
FDA approved Dec 2022. Smallest rechargeable SCS. Five recharges/year. Approved for chronic pain.
Updated Dec 2022Checked 10 Oct0 updates this week
Electrode placed in epidural space near spinal cord; pulse generator implanted under skin.
Uses low-dose BurstDR pattern mimicking natural brain firing. 23% more pain reduction than traditional SCS.
Patients control intensity via remote; physicians adjust during appointments.
| Spec | Eterna SCS |
|---|---|
| Size | World's smallest rechargeable SCSR (reported) |
| Recharges per year | 5R (reported) |
R reported by the company
Abbott Laboratories
Neuromodulation, DBS, spinal cord stimulation, medical devices
Abbott manufactures neuromodulation devices through St. Jude Medical (acquired 2017). Makes Liberta RC DBS for Parkinson's and Eterna SCS for chronic pain.